Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
Current Opinion in Pharmacology|August 7, 2003
Histone deacetylasesPaul A Marks, Thomas Miller, Victoria M RichonExpert Opinion on Investigational Drugs|November 30, 2002
Histone deacetylase inhibitors: from target to clinical trialsWilliam K Kelly, Owen A O'Connor, Paul A MarksProceedings of the National Academy of Sciences of the United States of America|December 15, 2004
Apoptotic and autophagic cell death induced by histone deacetylase inhibitorsYufang Shao, Zhonghua Gao, Paul A Marks, et al.Advances in Cancer Research|October 24, 2012
Mechanisms of resistance to histone deacetylase inhibitorsJu-Hee Lee, Megan L Choy, Paul A MarksProceedings of the National Academy of Sciences of the United States of America|November 2, 2010
Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agentsMandana Namdar, Gisela Perez, Lang Ngo, et al.Pharmaceutics|July 27, 2022
Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1Nishant Mohan, Atul Agrawal, Yi Shen, et al.Advances in Cancer Research|August 26, 2004
Histone deacetylase inhibitorsPaul A Marks, Victoria M Richon, Thomas Miller, et al.Proceedings of the National Academy of Sciences of the United States of America|April 12, 2012
Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell deathNoor Gammoh, Du Lam, Cindy Puente, et al.Cancer Research|September 6, 2005
Induction of polyploidy by histone deacetylase inhibitor: a pathway for antitumor effectsWei-Sheng Xu, Gisela Perez, Lang Ngo, et al.Genes & Development|April 7, 2006
Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modificationsDafna Nathan, Kristin Ingvarsdottir, David E Sterner, et al.Pageof 7